Cinacalcet Tablet, Film Coated
Product Images NDC 72162-1845

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cinacalcet (NDC 72162-1845). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cinacalcet-fig3 (Cinacalcet Fig3)

A line graph depicting calcium levels (mg/dL) over time in weeks for patients with parathyroid carcinoma (n=29). The x-axis shows weeks from baseline through titration and maintenance phases, and the y-axis represents calcium concentration. Data points include error bars indicating variability at each time point during the 80-week study period.*

FDA Label Image

Cinacalcet-fig4.jpg (Cinacalcet Fig4)

A line graph depicting calcium levels (mg/dL) over a period of 80 weeks, with data points shown weekly. The graph includes phases labeled 'Titration' and 'Maintenance,' and notes the number of subjects with intractable pHPT at the bottom. Error bars indicate variability at each time point.*

FDA Label Image

Cinacalcet-figure-1.jpg (Cinacalcet Figure 1)

A line graph titled 'Mean (SE) iPTH Values (Pooled Phase 3 Studies)' comparing iPTH levels (pg/ml) over 26 weeks between placebo and Cinacalcet groups. The x-axis represents weeks (0 to 26), and the y-axis displays iPTH levels from 0 to 1000 pg/ml. The Cinacalcet group shows a decreasing trend in iPTH levels, whereas the placebo group remains relatively steady.*

FDA Label Image

Cinacalcet-figure-2 (Cinacalcet Figure 2)

A line graph titled 'Mean (SE) Ca x P Values (Pooled Phase 3 Studies)' showing calcium-phosphorus product levels (mg/dL) over 26 weeks. Two lines represent placebo (dashed) and cinacalcet (solid), with cinacalcet values lower and decreasing over time compared to placebo. The x-axis shows weeks 0 to 26, and the y-axis shows Ca x P values from 0 to 70 mg/dL.*

FDA Label Image

Cinacalcet-str (Cinacalcet Str)

Chemical structure of cinacalcet hydrochloride, showing its molecular arrangement including aromatic rings, trifluoromethyl group, and amine with hydrochloride component.*

FDA Label Image

Label (Lbl721621845)

Label for Cinacalcet Tablets 90 mg film-coated oral tablets. The label indicates a package size of 30 tablets, with Bryant Ranch Prepack, Inc. as the relabeler and Alkem Laboratories Ltd. as the manufacturer. Storage instructions and a pharmacist note about dispensing patient package inserts are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.